Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Linker

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
Reported Incidence of Atrial Fibrillation Varies by Ethnicity and Presentation in the Multi-Ethnic Study of AtherosclerosisBenjamin Y Hsieh, Ting-Wei Ernie Liao, David T Linker
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 17, 2009
Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?Wayne C Levy, Dariush Mozaffarian, David T Linker, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|November 3, 2010
Factors affecting acceptance of a Web-based self-referral systemEung-Hun Kim, David T Linker, Anil Coumar, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 10, 2013
Impact of renal dysfunction on the Seattle Heart Failure ModelKairav P Vakil, Todd Dardas, Sunil Dhar, et al.
The American Journal of Cardiology|August 19, 2007
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptideHeidi T May, Benjamin D Horne, Wayne C Levy, et al.
European Journal of Heart Failure|January 24, 2009
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trialsWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Circulation|July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure ModelDariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
Circulation|March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failureWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
Reported Incidence of Atrial Fibrillation Varies by Ethnicity and Presentation in the Multi-Ethnic Study of AtherosclerosisBenjamin Y Hsieh, Ting-Wei Ernie Liao, David T Linker
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 17, 2009
Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?Wayne C Levy, Dariush Mozaffarian, David T Linker, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|November 3, 2010
Factors affecting acceptance of a Web-based self-referral systemEung-Hun Kim, David T Linker, Anil Coumar, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 10, 2013
Impact of renal dysfunction on the Seattle Heart Failure ModelKairav P Vakil, Todd Dardas, Sunil Dhar, et al.
The American Journal of Cardiology|August 19, 2007
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptideHeidi T May, Benjamin D Horne, Wayne C Levy, et al.
European Journal of Heart Failure|January 24, 2009
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trialsWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Circulation|July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure ModelDariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
Circulation|March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failureWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
Pageof 3